Phlebitis: The Term for Inflammation of Veins After Administration of Anesthesia
The medical term for inflammation of veins after administration of anesthesia is "phlebitis." This condition is a common complication of intravenous administration that can significantly affect clinical outcomes and patient satisfaction.
Understanding Phlebitis in Anesthesia
Phlebitis is characterized by inflammation of the vein wall, which can occur following the administration of anesthetic agents and other medications through intravenous routes. It represents one of the most frequent complications associated with intravenous cannulation.
Mechanisms and Pathophysiology
Phlebitis typically develops through several mechanisms:
- Chemical irritation: Anesthetic agents and their vehicles (solvents) can directly irritate the venous endothelium
- Mechanical trauma: From the cannula itself
- Infusion-related factors: Including rate, volume, and duration
- Patient-related factors: Such as age, sex, and vascular health
The pathophysiology involves:
- Irritation of the endothelium inducing venoconstriction
- Endothelial dysfunction
- Activation of inflammatory pathways (including nuclear factor kappa B, Wnt/β-catenin, and others) 1
- Upregulation of inflammatory mediators
Clinical Presentation
Phlebitis presents with several characteristic signs and symptoms:
- Feelings of tingling, burning, or discomfort at the injection site
- Pain along the course of the vein
- Swelling and redness at the injection site
- In more severe cases: streak formation, palpable venous cord, and warmth
- Later symptoms may include blistering, necrosis, and ulceration 2
Risk Factors
Several factors increase the risk of developing phlebitis:
Patient factors:
- Age over 65 years
- Female sex 3
Technical factors:
Medication factors:
Prevention and Management
Prevention strategies include:
Proper cannulation technique:
- Select appropriate vein size and cannula gauge
- Avoid veins on the back of the hand when possible
Dedicated cannulation:
- Use of a dedicated cannula for postoperative use decreases the incidence and severity of phlebitis (26.1% vs 63.3% with single cannula) 4
Medication considerations:
- Dilution of irritant medications
- Appropriate infusion rates
- Selection of less irritating anesthetic agents when possible
Monitoring:
- Regular assessment of IV sites
- Early detection and intervention
Differential Diagnosis
It's important to differentiate true phlebitis from:
- Local non-extravasation reactions (erythema around the cannula site, urticaria, local itching)
- Chemical phlebitis (burning sensation at cannula site, cramping along the vein) 2
- Extravasation ("tissuing") - leakage of fluid into surrounding tissues 6
Conclusion
Recognizing phlebitis early is crucial for preventing progression to more serious complications such as thrombophlebitis or venous thrombosis. The daily risk of complications ranges from 15% (day 1) to 30% (6 or more days) for peripheral cannulae 3, highlighting the importance of vigilant monitoring and appropriate preventive measures.